EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact on daptomycin resistance using combination of daptomycin plus ceftaroline in daptomycin-susceptible and -resistant Staphylococcus aureus

Nagendra N Mishra iD, Cody A Black, Wessam Abdelhady, Sabrina Farah, Naidelyn A Rodas, Josue Brizuela, Clarissa Bustamante Lopez, Jorge N Artaza, George Sakoulas, Warren E Rose iD

FEMS Microbes · 08.01.2026 · 7

DOI: 10.1093/femsmc/xtag013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEMS Microbes, online erschienen am 05.03.2026. Verfasst von Nagendra N Mishra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, United States. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH, NIAID, UCLA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Persistent Staphylococcus aureus infections treated with prolonged daptomycin (DAP) can select for DAP resistance (DAP-R), reinforcing the need for combination strategies that both improve killing and constrain resistance evolution. Prior work suggests the DAP+ceftaroline (CPT) combination can deliver synergistic killing, prevent emergence of DAP-R, and resensitize DAP-R subpopulations toward a DAP-susceptible (DAP-S) phenotype. Here, using a clinically derived, MSSA isogenic DAP-S (616)/DAP-R (703) strain pair, we evaluated DAP+CPT activity across in vitro assays, ex vivo models, and an in vivo experimental infective endocarditis (IE) model, and integrated ultra-deep targeted sequencing to link phenotypic responses to genomic adaptation. DAP+CPT produced enhanced killing of both strains in vitro and ex vivo, improved target-tissue clearance of the DAP-R strain in vivo, prevented emergence of DAP-R in the DAP-S parental strain in vitro and ex vivo, and resensitized the DAP-R strain toward a DAP-S phenotype ex vivo. Genomically, ultra-deep sequencing of resistance loci (thousands-fold coverage) identified fixed background divergence versus the N315 reference and revealed regimen-dependent selection in membrane-stress pathways, including a high-frequency mixed mprF subpopulation consistent with DAP-driven heterogeneity under monotherapy, contrasted by distinct locus-level changes under combination exposure. In addition, coverage profiling detected a large, combination-associated mobile-element/prophage gene-content event in the 703 background affecting an immune-evasion/β-hemolysin–converting region, highlighting that antibiotic pressure can couple resistance dynamics with pathogenesis-relevant genome remodeling. Together, these data show that DAP+CPT provides potent activity beyond synergistic killing—improving clearance while constraining or reshaping resistance evolution—and they define genomic signatures that help explain divergent evolutionary trajectories under DAP alone versus DAP+CPT.

Schlagwörter

Stichwörter der Autor:innen

MSSAceftarolinedaptomycingeneticsmechanismsresistance

Autor:innen und Institutionen

  • Division of Infectious Diseases, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, United States.
  • David Geffen School of Medicine, University of California, Los Angeles (UCLA), CA 90095, United States.
  • College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, United States.
  • Joe R. and Teresa Lozano Long School of Medicine, The University of Texas Health at San Antonio, San Antonio, TX 78229, United States.
  • Department of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, United States.
  • Division of Host-Microbe Systems and Therapeutics, University of California San Diego, School of Medicine, La Jolla, CA, United States.

ORCID-Profile: Nagendra N Mishra, Warren E Rose

Förderung

  • NIH
  • NIAID
  • UCLA

Zitieren

APA

Mishra, N. N., Black, C. A., Abdelhady, W., Farah, S., Rodas, N. A., Brizuela, J., Lopez, C. B., Artaza, J. N., Sakoulas, G., & Rose, W. E. (2026). Impact on daptomycin resistance using combination of daptomycin plus ceftaroline in daptomycin-susceptible and -resistant Staphylococcus aureus. FEMS Microbes, 7. https://doi.org/10.1093/femsmc/xtag013

Vancouver

Mishra NN, Black CA, Abdelhady W, Farah S, Rodas NA, Brizuela J, et al. Impact on daptomycin resistance using combination of daptomycin plus ceftaroline in daptomycin-susceptible and -resistant Staphylococcus aureus. FEMS Microbes. 2026;7. doi:10.1093/femsmc/xtag013

BibTeX
@article{Mishra2026,
  author = {Mishra, Nagendra N and Black, Cody A and Abdelhady, Wessam and Farah, Sabrina and Rodas, Naidelyn A and Brizuela, Josue and Lopez, Clarissa Bustamante and Artaza, Jorge N and Sakoulas, George and Rose, Warren E},
  title = {Impact on daptomycin resistance using combination of daptomycin plus ceftaroline in daptomycin-susceptible and -resistant Staphylococcus aureus},
  journal = {FEMS Microbes},
  year = {2026},
  volume = {7},
  doi = {10.1093/femsmc/xtag013}
}
Kostenlos starten →